AI-Powered Medical Diagnostics: The Technology Behind COVRIAD
COVRIAD employs a cutting-edge AI engine powered by convolutional neural networks (CNNs) to deliver precise pattern recognition and anomaly detection. Trained on a diverse dataset of over 200,000 chest X-rays, it ensures consistent accuracy across various medical conditions and demographics. Its cloud-based architecture allows for seamless scalability, making it suitable for both small clinics and large healthcare networks. With fast diagnostic results and smooth integration into existing workflows, COVRIAD is setting a new standard in modern medical diagnostics.
The Vision Behind COVRIAD
COVRIAD was developed to bridge the gap in diagnostic accuracy and accessibility, particularly in regions where healthcare resources are limited. By leveraging AI and machine learning, this tool democratizes access to high-quality medical diagnostics, ensuring that every patient, regardless of location or socioeconomic status, can receive timely care.
Certifications and Approvals
Award-Winning Innovation
COVRIAD earned the prestigious Award for Innovation in 2021, solidifying its position as a leader in healthcare technology.
Discover COVRIAD
High Precision
Trained on 200,000 X-rays for unmatched diagnostic accuracy.
Wide Scope
Detects 15 diseases, including COVID-19 and critical pulmonary conditions.
Cost-Effective
Affordable diagnostics designed for all healthcare providers.
User-Friendly
Intuitive interface for seamless integration into workflows.
Diseases Detectable by COVRIAD
COVRIAD is a diagnostic system capable of detecting a wide range of respiratory conditions. It offers accurate and timely identification of various lung-related disorders, helping in early diagnosis and effective treatment.
COVRIAD can diagnose the following diseases:
- COVID-19
- Pneumonia
- Tuberculosis
- Lung Cancer
- Asthma
- Chronic Obstructive Pulmonary Disease (COPD)
- Bronchitis
- Pulmonary Edema
- Pleural Effusion
- Interstitial Lung Disease
- Sarcoidosis
- Emphysema
- Pulmonary Fibrosis
- Acute Respiratory Distress Syndrome (ARDS)
- Lung Nodules
Our Panel of Experts
Meet our globally recognized healthcare experts who are redefining medical excellence.
Dr. Najam ud Din
Consultant Radiologist, CEO Aznostics Diagnostic Centers
Pakistan
Dr. Mohammad K. Khan, MD LLC
St. Luke's University Hospital, Pennsylvania, USA
USA
Dr. Junaid Baloch, MD
Director CarePoint Health Foundation Inc.
NJ, USA
Dr. Muhammad Waseem Awan
Consultant Radiologist & Head Radiology Dept, KRL Hospital, MBBS, FCPS
Pakistan
Dr. Junaid Baloch, MD
MBBS, MHA, MS, CHAM, Director CarePoint Health Foundation Inc.
NJ, USA
Dr. Atta Ullah
Radiologist & Sonologist, MBBS, MCPS
Pakistan
Dr. Jawad Baloch, MD
MBBS, MS Internal Medicine & Cardiology
New Jersey, USA
Dr. Maryam Sajid
MBBS, Fauji Foundation Hospital
Rawalpindi, Pakistan
Dr. Saira Batool
MBBS, MRCP UK, Consultant Medicine Scotland
UK
COVRIAD AI vs. International Solution (Canadian Solution)
Qualitative Metrics for COVID Detection
| # | Findings | COVRIAD (Pakistan) | COVID-Net (Canada) |
|---|---|---|---|
| 1 | Sensitivity | 100% | 86.79% |
| 2 | Overall Accuracy | 95.08% | 52.38% |
| 3 | Specificity | 93.15% | 27.39%r |
